Clinical trials
Observational Hemoglobinopathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 10 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 4 |
| Hospital Universitari Vall d'Hebron Research Institute | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Bangladesh Bioscience Research Group | 2 |
| Società Italiana Talassemie ed Emoglobinopatie | 2 |
| St. Jude Children's Research Hospital | 2 |
| Bacha Khan Medical College | 1 |
| Beam Therapeutics Inc. | 1 |
| Columbia University | 1 |
| Cyprus Institute of Neurology and Genetics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobinopathies | 28 |
| Anemia, Sickle Cell | 15 |
| Thalassemia | 12 |
| Anemia | 5 |
| beta-Thalassemia | 5 |
| Fanconi Anemia | 4 |
| Hematologic Neoplasms | 4 |
| Immunologic Deficiency Syndromes | 4 |
| Malaria | 3 |
| alpha-Thalassemia | 3 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.